Thrombus imaging aptamers and methods of using same
Provided herein are imaging agents, antidotes to the imaging agents and methods of using the same to image a thrombus or blood clot or thrombin including sites of thrombin accumulation and to diagnose and treat thrombosis. The imaging agents include an aptamer capable of binding the thrombus or thrombin in particular linked to a reporter moiety. The imaging agents may be used to label the thrombus or sites of thrombin accumulation. Antidotes capable of binding to the aptamer in the imaging agent are also provided. The antidotes may further be linked to a quencher capable of quenching the reporter moiety.
1. A method for imaging a thrombus or sites of thrombin accumulation comprising
administering an imaging agent to a subject, wherein said imaging agent comprises an aptamer that binds the thrombus or thrombin linked to a reporter moiety, wherein the aptamer comprises a nucleotide sequence having at least 70% sequence identity to SEQ ID NO: 1 or SEQ ID NO:8-10, wherein said aptamer and said reporter moiety are linked by a covalent bond at the 5′ or 3′ end of said aptamer, and generating an image of at least a portion of the subject using an imaging modality, wherein the imaging agent labels said thrombus or site of thrombin accumulation in the image by binding of the aptamer to the thrombus.
2. The method of claim 1 , wherein said reporter moiety is selected from the group consisting of a fluorophore moiety, an optical moiety, a magnetic moiety, a radiolabel moiety, an X-ray moiety, an ultrasound imaging moiety, a photoacoustic imaging moiety, a nanoparticle-based moiety, and a combination of two or more of the recited moieties.
3. The method of claim 1 , wherein said imaging modality is selected from the group consisting of positron-emission tomography (PET), single photon emission computed tomography (SPECT), magnetic resonance imaging (MRI), optical imaging (OI), ultrasound, photoacoustic imaging (PAI), near-infrared fluorescence (NIRF) imaging, and computed tomography (CT).
4. The method of claim 1 , wherein said imaging agent comprises the aptamer of SEQ ID NO: 1.
5. The method of claim 1 , further comprising administering an antidote selected from the group consisting of SEQ ID NO: 2, SEQ ID NO: 3 and SEQ ID NO: 4 to reverse or block the labeling of the thrombus or thrombin by the imaging agent.
6. The method of claim 1 , wherein said reporter moiety comprises a fluorophore moiety.
7. The method of claim 1 , wherein said reporter moiety comprises Alexa Fluor 680.
8. The method of claim 1 , wherein said aptamer and said reporter moiety are linked by a covalent bond.
9. The method of claim 8 , wherein said aptamer and said reporter moiety are linked at the 5′ or 3′ end of said aptamer.
10. The method of claim 1 , wherein said aptamer and said reporter moiety are linked by a tag system.
11. The method of claim 10 , wherein said tag system is selected from the group consisting of biotin/avidin, biotin/streptavidin, and biotin/NeutrAvidin.